Chih‐Feng Chian

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

Yi‐Long Wu, Ying Cheng, Jianying Zhou et al. · The Lancet Respiratory Medicine · 2020 · 249 citations

Oncology, Met Amplification, Medicine +10

Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

Gee‐Chen Chang, Chao‐Hua Chiu, Chong‐Jen Yu et al. · The Lancet Respiratory Medicine · 2023 · 137 citations

Tobacco Control, Family Medicine, Cancer Epidemiology +10

Echogenic Swirling Pattern as a Predictor of Malignant Pleural Effusions in Patients With Malignancies

Chih‐Feng Chian, Wen‐Lin Su, Li-Hui Soh et al. · CHEST Journal · 2004 · 107 citations

Malignant Pleural Effusions, Thoracic Ultrasound, Pleural Effusion +2

Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury

Yung-Yang Liu, Chi‐Huei Chiang, Shih‐Chieh Hung et al. · PLoS ONE · 2017 · 70 citations · Full text

Nivolumab-induced myasthenia gravis in a patient with squamous cell lung carcinoma

Yu‐Hsiu Chen, Feng‐Cheng Liu, Chang-Hung Hsu et al. · Medicine · 2017 · 47 citations · Full text